Ikarian Capital, LLC Rapt Therapeutics, Inc. Put Options Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$6.87 - $26.45 $1.29 Million - $4.96 Million	187,400 Added 318.71%	246,200 $2.21 Million
Q4 2023 Feb 14, 2024	BUY	$11.28 - $25.46 $663,264 - $1.5 Million	58,800 New	58,800 $1.46 Million
Q3 2021 Nov 15, 2021	SELL	$29.86 - $39.47 $10.5 Million - $13.8 Million	-350,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$17.99 - $40.02 $6.02 Million - $13.4 Million	334,400 Added 2143.59%	350,000 $11.1 Million
Q3 2020 Nov 16, 2020	BUY	$21.6 - $37.5 $336,960 - $585,000	15,600 New	15,600 $503,000

104

27.1M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $24.9M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.